🇺🇸 FDA
Patent

US 11684657

HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject

granted A61KA61K2239/38A61K2239/54

Quick answer

US patent 11684657 (HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject) held by The Board of Regents of the University of Texas System expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2239/38, A61K2239/54, A61K38/00, A61K38/08